Comparison of the Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients with or Susceptible to Thromboembolic Events

F Shahbazi, F Heydarpour, A Kamari… - Iranian South Medical …, 2023 - ismj.bpums.ac.ir
Background: The similar efficacy of rivaroxaban and warfarin in thromboembolic events was
recognized in clinical trials. But there are a few studies about the comparison of these …

[PDF][PDF] 2019 台灣腦中風學會非維他命K 拮抗劑口服抗凝血劑用於心房纖維顫動患者中風預防治療指引

林雅如, 黃英庭, 崔百青, 蔡力凱, 鍾芷萍, 郭書帆… - 台灣中風醫誌, 2019 - stroke.org.tw
預防的相關研究, 皆註明為非瓣膜性AF (nonvalvular AF, NVAF). 這個名詞似乎指是不能有任何
心臟瓣膜相關問題, 但實際臨床狀況並非如此, 反易造成誤解. 2016 年歐洲心臟學會之AF …

[HTML][HTML] Use of non-vitamin k dependent oral anticoagulant in ischemic stroke

H Park, J Yoo - Journal of the Korean Neurological Association, 2022 - jkna.org
Atrial fibrillation (AF) is associated with an increased incidence of ischemic stroke and
transient ischemic attack. A confluence of various factors such as blood stasis, endothelial …

Reperfusion Therapy Brings Apixaban Administration Forward in Patients with Nonvalvular Arterial Fibrillation with Anterior Circulation Large Vessel Occlusion or …

N Shimamura, M Naraoka, K Uchida, K Tokuda… - World Neurosurgery, 2022 - Elsevier
Objective The initiation of anticoagulant administration after large vessel occlusion (LVO) or
stenosis with nonvalvular arterial fibrillation (NAVF) is controversial. We evaluate the timing …

[HTML][HTML] Фармакодинамика оральных антикоагулянтов у больных с фибрилляцией предсердий в остром периоде ишемического инсульта

ВИ Петров, АС Герасименко… - Фармация и …, 2020 - cyberleninka.ru
Введение. Каждый пятый ишемический инсульт обусловлен наличием у пациента в
анамнезе фибрилляции предсердий. Для предотвращения тромбоэмболических …

Computed tomography images under the nomogram mathematical prediction model in the treatment of cerebral infarction complicated with nonvalvular atrial …

Y Zhu, H Cheng, R Min, T Wu - Contrast Media & Molecular …, 2022 - Wiley Online Library
The aim of this work was to explore the effect of the nomogram mathematical model on the
treatment of cerebral infarction complicated with nonvalvular atrial fibrillation (NVAF) and …

[HTML][HTML] Update of anticoagulation use in cardioembolic stroke with a special reference to endovascular treatment

A Safouris, K Psychogios, L Palaiodimou… - Journal of …, 2024 - synapse.koreamed.org
Cardioembolic stroke is a major cause of morbidity, with a high risk of recurrence, and
anticoagulation represents the mainstay of secondary stroke prevention in most patients …

Anticoagulation prescribing practice following ischaemic strokes in the setting of non‐valvular atrial fibrillation

S Tan, C Williams, P Choi - Internal Medicine Journal, 2021 - Wiley Online Library
It is well established that anticoagulation following an ischaemic stroke in the setting of non‐
valvular atrial fibrillation is an effective means of secondary prevention. However, there is a …

[PDF][PDF] 허혈뇌졸중에서비타민K 비의존경구항응고제의사용

H Park, J Yoo - 2022 - kumel.medlib.dsmc.or.kr
Atrial fibrillation (AF) is associated with an increased incidence of ischemic stroke and
transient ischemic attack. A confluence of various factors such as blood stasis, endothelial …

[PDF][PDF] 허혈뇌졸중에서비타민K 비의존경구항응고제의사용

박형종, 유준상 - 대한신경과학회지, 2022 - scholar.archive.org
Atrial fibrillation (AF) is associated with an increased incidence of ischemic stroke and
transient ischemic attack. A confluence of various factors such as blood stasis, endothelial …